Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice

1989 ◽  
Vol 27 (3-4) ◽  
pp. 319-321 ◽  
Author(s):  
J. Björk ◽  
S. Kleinau
1983 ◽  
Vol 158 (6) ◽  
pp. 2007-2015 ◽  
Author(s):  
N Kaibara ◽  
T Hotokebuchi ◽  
K Takagishi ◽  
I Katsuki

The effect of the immunosuppressive agent cyclosporin A (CS-A) on collagen arthritis in Sprague-Dawley rats is investigated. A 14-d course of CS-A treatment at doses of 15 mg/kg per day or more, begun on the same day as type II collagen immunization, suppressed the development of arthritis as well as humoral and delayed-type hypersensitivity (DTH) skin test responses to type II collagen, possibly by interfering with helper T cells. Additional studies demonstrated that CS-A treatment only during the induction phase of immunity proved to be successful. When CS-A treatment was started only during the immediately preclinical phase of arthritis or after the disease onset, a significant enhancement of the disease was obtained in a dose-dependent manner. This enhancement was accompanied by an augmentation of DTH skin reactions, while antibody responses were either suppressed or unaffected. These results appear to be attributable at least in part to a suppressive effect of CS-A on a population of suppressor T cells, thus resulting in a T cell-mediated helper effect. It is therefore reasonable to assume that the paradoxical effects of CS-A on collagen arthritis in rats might be caused by an altering of the sensitive balance of the two regulatory subpopulations of T cells. It is also possible that cell-mediated immune responses may play an important role in influencing the course of the disease.


2010 ◽  
Vol 31 (5) ◽  
pp. 595-603 ◽  
Author(s):  
Samjin Choi ◽  
Yeon-Ah Lee ◽  
Seung-Jae Hong ◽  
Gi-Ja Lee ◽  
Sung Wook Kang ◽  
...  

1985 ◽  
Vol 35 (2) ◽  
pp. 252-260 ◽  
Author(s):  
Nobuhiro Kaibara ◽  
Masahiro Morinaga ◽  
Chikafumi Arita ◽  
Takao Hotokebuchi ◽  
Kenji Takagishi

1986 ◽  
Vol 29 (9) ◽  
pp. 1131-1138 ◽  
Author(s):  
Marcia L. Bliven ◽  
Paul H. Wooley ◽  
Mark B. Pepys ◽  
Ivan G. Otterness

1981 ◽  
Vol 154 (3) ◽  
pp. 688-700 ◽  
Author(s):  
P H Wooley ◽  
H S Luthra ◽  
J M Stuart ◽  
C S David

A model of arthritis was established by the injection of type II collagen into mice. Only mice bearing the H-2q haplotype were susceptible to the disease. Susceptibility was further mapped by the use of recombinant strains on the Iq locus. Type II collagen arthritis was observed in the (resistant X susceptible) F1 cross. Mice strains were designated high, intermediate, or low responders with respect to the anti-type II antibody levels measured by radioimmunoassay. Arthritis-susceptible strains were all classified as high antibody responders. The clinical and histological appearance of type II collagen arthritis in the mouse indicates that it may be a good animal model for the investigation of various immunogenetic traits in rheumatoid arthritis.


1986 ◽  
Vol 19 (5-6) ◽  
pp. 320-322
Author(s):  
D. Westmacott ◽  
J. E. Hawkes ◽  
J. Wadsworth ◽  
C. H. Cashin ◽  
A. Cline ◽  
...  

2003 ◽  
Vol 171 (7) ◽  
pp. 3493-3499 ◽  
Author(s):  
Johan Bäcklund ◽  
Kutty Selva Nandakumar ◽  
Robert Bockermann ◽  
Lucia Mori ◽  
Rikard Holmdahl

1985 ◽  
Vol 162 (5) ◽  
pp. 1531-1545 ◽  
Author(s):  
S M Helfgott ◽  
R Dynesius-Trentham ◽  
E Brahn ◽  
D E Trentham

A type II collagen-specific arthritogenic lymphokine has been identified in the rat. Arthritogenic factor (AF) is a 65 kD protein generated in vitro by T cells from rats with collagen arthritis, and it induces an erosive, proliferative synovitis when injected into the knee joint of syngeneic naive recipients. Complement does not appear to be required. These data identify a potential T cell-mediated effector mechanism in this model, and suggest that AF may function in other inflammatory synovial diseases.


1982 ◽  
Vol 12 (5) ◽  
pp. 650-656 ◽  
Author(s):  
S. A. Jones ◽  
A. J. Kennedy ◽  
N. A. Roberts

1987 ◽  
Vol 105 (2) ◽  
pp. 447-453 ◽  
Author(s):  
Mary E. Englert ◽  
Kim M. Ferguson ◽  
Carmen R. Suarez ◽  
Theresa M. Sapp ◽  
Arnold L. Oronsky ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document